Brief: FDA Approves Alcon’S BRYTL Eye Drops
BRIEF-FDA Approves Alcon’S BRYTL Eye Drops Oct 16 (Reuters) - Alcon AG ALCC.S:
FDA APPROVES ALCON’S BRYTLY REDNESS RELIEVER EYE DROPS FOR UP TO 12 HOURS OF WHITER, BRIGHTER-LOOKING EYES
Source text: ID:nBw1Bjvnqa
Further company coverage: ALCC.S
((reuters.briefs@thomsonreuters.com;))
Recent news on Alcon AG
See all newsSwiss stocks - Factors to watch on November 12
Alcon AG reports results for the quarter ended September 30 - Earnings Summary
Alcon shares fall as tighter eye-care market outlook raises growth concerns (updated)
Alcon seen down after sales miss, tighter outlook
Swiss stocks - Factors to watch on November 11